Bilateral central serous chorioretinopathy post-COVID-19
Copyright © 2021 Elsevier Masson SAS. All rights reserved..
Coronavirus disease (COVID-19) can result in many ocular manifestations. We report a rare case of bilateral central serous chorioretinopathy post-infection with COVID-19 in a 38-year-old woman who presented with bilateral blurred vision 1 month after infection with COVID-19. She reported fever, cough, and shortness of breath and was COVID-PCR positive. During her 10-day hospital stay, she received oxygen, antibiotics, heparin and corticosteroids intravenously and then orally. After her recovery from COVID-19, the patient developed progressive visual loss in both eyes: her corrected visual acuity was 3/10 in both eyes, the anterior segment was normal, and the vitreous was clear. Fundus examination, optical coherence tomography and fluorescein angiography showed bilateral serous retinal detachments. Her course was characterized by improvement in visual acuity and regression of the retinal detachments. Central serous chorioretinopathy can occur after COVID-19 infection due to the administration of corticosteroids; thus, ophthalmologic examination is essential to detect ocular involvement as early as possible.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Journal francais d'ophtalmologie - 44(2021), 10 vom: 30. Dez., Seite 1484-1490 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
|---|
| Beteiligte Personen: |
Mahjoub, A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 30.11.2021 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jfo.2021.10.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332947017 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332947017 | ||
| 003 | DE-627 | ||
| 005 | 20231225220625.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.jfo.2021.10.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1109.xml |
| 035 | |a (DE-627)NLM332947017 | ||
| 035 | |a (NLM)34756744 | ||
| 035 | |a (PII)S0181-5512(21)00506-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Mahjoub, A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bilateral central serous chorioretinopathy post-COVID-19 |
| 246 | 3 | 3 | |a Choriorétinopathie séreuse centrale bilatérale post-COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.11.2021 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Coronavirus disease (COVID-19) can result in many ocular manifestations. We report a rare case of bilateral central serous chorioretinopathy post-infection with COVID-19 in a 38-year-old woman who presented with bilateral blurred vision 1 month after infection with COVID-19. She reported fever, cough, and shortness of breath and was COVID-PCR positive. During her 10-day hospital stay, she received oxygen, antibiotics, heparin and corticosteroids intravenously and then orally. After her recovery from COVID-19, the patient developed progressive visual loss in both eyes: her corrected visual acuity was 3/10 in both eyes, the anterior segment was normal, and the vitreous was clear. Fundus examination, optical coherence tomography and fluorescein angiography showed bilateral serous retinal detachments. Her course was characterized by improvement in visual acuity and regression of the retinal detachments. Central serous chorioretinopathy can occur after COVID-19 infection due to the administration of corticosteroids; thus, ophthalmologic examination is essential to detect ocular involvement as early as possible | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Central serous chorioretinopathy | |
| 650 | 4 | |a Choriorétinopathie séreuse centrale | |
| 650 | 4 | |a Corticosteroids | |
| 650 | 4 | |a Corticoïdes | |
| 650 | 4 | |a Décollements séreux rétiniens | |
| 650 | 4 | |a Ink-blot leakage | |
| 650 | 4 | |a Points de fuite | |
| 650 | 4 | |a Serous retinal detachments | |
| 700 | 1 | |a Dlensi, A |e verfasserin |4 aut | |
| 700 | 1 | |a Romdhane, A |e verfasserin |4 aut | |
| 700 | 1 | |a Ben Abdesslem, N |e verfasserin |4 aut | |
| 700 | 1 | |a Mahjoub, A |e verfasserin |4 aut | |
| 700 | 1 | |a Bachraoui, C |e verfasserin |4 aut | |
| 700 | 1 | |a Mahjoub, H |e verfasserin |4 aut | |
| 700 | 1 | |a Ghorbel, M |e verfasserin |4 aut | |
| 700 | 1 | |a Knani, L |e verfasserin |4 aut | |
| 700 | 1 | |a Krifa, F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal francais d'ophtalmologie |d 1993 |g 44(2021), 10 vom: 30. Dez., Seite 1484-1490 |w (DE-627)NLM000357944 |x 1773-0597 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2021 |g number:10 |g day:30 |g month:12 |g pages:1484-1490 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jfo.2021.10.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2021 |e 10 |b 30 |c 12 |h 1484-1490 | ||